Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,451 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Serological surveillance of SARS-CoV-2: Six-month trends and antibody response in a cohort of public health workers.
Harris RJ, Whitaker HJ, Andrews NJ, Aiano F, Amin-Chowdhury Z, Flood J, Borrow R, Linley E, Ahmad S, Stapley L, Hallis B, Amirthalingam G, Höschler K, Parker B, Horsley A, Brooks TJG, Brown KE, Ramsay ME, Ladhani SN. Harris RJ, et al. Among authors: parker b. J Infect. 2021 May;82(5):162-169. doi: 10.1016/j.jinf.2021.03.015. Epub 2021 Mar 22. J Infect. 2021. PMID: 33766553 Free PMC article.
Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection.
Zuo J, Dowell AC, Pearce H, Verma K, Long HM, Begum J, Aiano F, Amin-Chowdhury Z, Hoschler K, Brooks T, Taylor S, Hewson J, Hallis B, Stapley L, Borrow R, Linley E, Ahmad S, Parker B, Horsley A, Amirthalingam G, Brown K, Ramsay ME, Ladhani S, Moss P. Zuo J, et al. Among authors: parker b. Nat Immunol. 2021 May;22(5):620-626. doi: 10.1038/s41590-021-00902-8. Epub 2021 Mar 5. Nat Immunol. 2021. PMID: 33674800 Free PMC article.
Author Correction: Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection.
Zuo J, Dowell AC, Pearce H, Verma K, Long HM, Begum J, Aiano F, Amin-Chowdhury Z, Hoschler K, Brooks T, Taylor S, Hewson J, Hallis B, Stapley L, Borrow R, Linley E, Ahmad S, Parker B, Horsley A, Amirthalingam G, Brown K, Ramsay ME, Ladhani S, Moss P. Zuo J, et al. Among authors: parker b. Nat Immunol. 2021 Jul;22(7):928. doi: 10.1038/s41590-021-00957-7. Nat Immunol. 2021. PMID: 34017126 Free PMC article. No abstract available.
Direct healthcare resource utilisation, health-related quality of life, and work productivity in patients with moderate rheumatoid arthritis: an observational study.
Galloway J, Edwards J, Bhagat S, Parker B, Tan AL, Maxwell J, Wallington M, Blanthorn-Hazell S, Bellamy C, Cole Z. Galloway J, et al. Among authors: parker b. BMC Musculoskelet Disord. 2021 Mar 13;22(1):277. doi: 10.1186/s12891-021-04110-1. BMC Musculoskelet Disord. 2021. PMID: 33714274 Free PMC article.
Early infection risk in patients with systemic lupus erythematosus treated with rituximab or belimumab from the British Isles Lupus Assessment Group Biologics Register (BILAG-BR): a prospective longitudinal study.
Rodziewicz M, Dyball S, Lunt M, McDonald S, Sutton E, Parker B, Bruce IN; British Isles Lupus Assessment Group Biologics Register (BILAG-BR) consortium. Rodziewicz M, et al. Among authors: parker b. Lancet Rheumatol. 2023 May;5(5):e284-e292. doi: 10.1016/S2665-9913(23)00091-7. Lancet Rheumatol. 2023. PMID: 38251591 Free article.
Pausing drugs and spacing vaccines: an open question.
Rodziewicz M, Dyball S, Bruce I, Parker B. Rodziewicz M, et al. Among authors: parker b. Lancet Rheumatol. 2021 Oct;3(10):e683. doi: 10.1016/S2665-9913(21)00274-5. Epub 2021 Sep 22. Lancet Rheumatol. 2021. PMID: 34580663 Free PMC article. No abstract available.
The potential overlapping populations for treatment with belimumab and rituximab using current NHS England and National Institute for Health and Care Excellence Guidelines in England and Wales.
McCarthy EM, Sutton E, Nesbit S, Parker B, Jayne D, Griffiths B, Isenberg DA, Rahman A, Gordon C, D'Cruz DP, Rhodes B, Lanyon P, Vital EM, Yee CS, Edwards CJ, Teh LS, Akil M, McHugh NJ, Zoma A, Bruce IN; British Isles Lupus Assessment Group Biologics Register. McCarthy EM, et al. Among authors: parker b. Rheumatology (Oxford). 2017 Jun 1;56(6):1041-1043. doi: 10.1093/rheumatology/kex044. Rheumatology (Oxford). 2017. PMID: 28431104 Free PMC article. No abstract available.
1,451 results